Tables
- TABLE 1
Participant characteristics and outcomes according to RE-AIM framework
Reach Total referrals 100 Attended initial assessment 71 Number of home visits per patient 1 (1–4) Number of phone calls per patient 7 (3–7) Completion 53 Characteristics Age years 71±12 Male/female 28/43 FEV1 % predicted 57±22 Long-term oxygen therapy 13 Diagnoses COPD 49 Asthma 8 Bronchiectasis 7 Interstitial lung disease 4 Pulmonary hypertension 2 Cystic fibrosis 1 Reason for HBPR choice Symptom limitation 32 Work commitments 24 Transportation 15 Effectiveness Outcomes Baseline Change following HBPR (n=53) 6MWD m 360 (218–541) 24 (6–34)# CRQ score Dyspnoea 15 (10–18) 3 (1–5)# Fatigue 15 (11–18) 2 (1–3)# Emotional function 35 (28–39) 2 (0–3) Mastery 20 (16–23) 2 (1–3)# CAT score 18 (13–22) −2 (−3–1)# HADS score Anxiety 5 (2–9) −1 (−2–0) Depression 5 (2–9) 0 (−2–1) mMRC score 2 (1–3) 34 (64%) score unchanged 19 (36%) score improved Adoption Staff trained 7 Implementation Programme modification 20 Pedometer use 20 Home diary completion 46 Maintenance Pilot period 1 year >3 years Data are n, median (interquartile range) or mean±sd. n=71 unless otherwise stated. RE-AIM: Reach, Effectiveness, Adoption, Implementation, Maintenance; FEV1: forced expiratory volume in 1 s; COPD: chronic obstructive pulmonary disease; HBPR: home-based pulmonary rehabilitation; 6MWD: 6-min walk distance; CRQ: Chronic Respiratory Questionnaire; CAT: COPD Assessment Test; HADS: Hospital Anxiety and Depression Scale; mMRC: modified Medical Research Council dyspnoea scale. #: clinically important change.